Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Vascular Endothelial Growth Factors and Risk of Cardio-renal Events: Results from the CREDENCE trial

    American Heart Journal Date published:

  • Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

    The Lancet Regional Health - Western Pacific Date published:

  • The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Calciphylaxis episodes in the Australia and New Zealand Dialysis and Transplant Registry

    Kidney International Reports Date published:

  • Alternative klinische Studiendesigns für die Nephrologieforschung

    Innovationen in der Nephrologie Date published:

  • Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

    Canadian Journal of Kidney Health and Disease Date published:

  • Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points

    Clinical Journal of the American Society of Nephrology Date published:

  • Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team.

    Journal of the American Society of Nephrology Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

    Kidney International Reports Date published:

  • Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    The Lancet Date published:

  • Impact of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort

    Journal of the American Society of Nephrology Date published:

  • Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Journal of the American Society of Nephrology Date published:

  • Continued Improvement of Itch-Related Quality of Life in CKD-Associated Pruritis (CKD-aP) Patients Treated with Difelikefalin

    Journal of the American Society of Nephrology Date published:

  • The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

    Kidney International Reports Date published: